Skip to Content

Alligator Bioscience AB ATORX

Morningstar Rating
SEK 0.99 +0.02 (2.26%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ATORX is trading at a 44% discount.
Price
SEK 0.98
Fair Value
SEK 9.44
Uncertainty
Extreme
1-Star Price
SEK 3.67
5-Star Price
SEK 5.44
Economic Moat
Fvv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ATORX is a good fit for your portfolio.

Trading Information

Previous Close Price
SEK 0.97
Day Range
SEK 0.961.00
52-Week Range
SEK 0.341.36
Bid/Ask
SEK 0.99 / SEK 1.00
Market Cap
SEK 654.01 Mil
Volume/Avg
700,077 / 4.0 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
7.50
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
59

Valuation

Metric
ATORX
Price/Earnings (Normalized)
Price/Book Value
53.95
Price/Sales
7.50
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ATORX
Quick Ratio
0.76
Current Ratio
0.79
Interest Coverage
−517.57
Quick Ratio
ATORX

Profitability

Metric
ATORX
Return on Assets (Normalized)
−151.88%
Return on Equity (Normalized)
−375.21%
Return on Invested Capital (Normalized)
−287.63%
Return on Assets
ATORX
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRJfhknzlpgbQrp$571.0 Bil
VRTX
Vertex Pharmaceuticals IncQfmctlhtwZgxrkwb$107.8 Bil
REGN
Regeneron Pharmaceuticals IncJmgctybmHxxnq$106.1 Bil
MRNA
Moderna IncLlckkcwgZshx$42.3 Bil
ARGX
argenx SE ADRWfqsnhfqXbl$23.7 Bil
BNTX
BioNTech SE ADRZbrqnrqTqy$22.1 Bil
ALNY
Alnylam Pharmaceuticals IncNqspxmwytLpswg$19.4 Bil
BMRN
Biomarin Pharmaceutical IncWkddthhLwzbzw$16.7 Bil
RPRX
Royalty Pharma PLC Class ANwbqkyhhytTcfxyjc$13.6 Bil
INCY
Incyte CorpSmkxbxvcQntbk$12.8 Bil

Sponsor Center